Dr. Elsayed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7 Wilson CV
Hillsborough, NJ 08844Phone+1 908-874-3982
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Nassau University Medical CenterResidency, Internal Medicine, 1996 - 1999
University of Gezira Faculty of MedicineClass of 1990
Certifications & Licensure
NJ State Medical License 2002 - 2025
DC State Medical License 1999 - 2020
VA State Medical License 1999 - 2006
Publications & Presentations
PubMed
- 10 citationsPreclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.Min Chul Kwon, Jan Willem Thuring, Olivier Querolle, Xuedong Dai, Tinne Verhulst
Blood. 2024-09-12 - 22 citationsEffects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma.Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti, Raluca Verona, Diego Vieyra
Blood Advances. 2023-02-28 - Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti, Arnob Banerjee, Tara Stephenson
Targeted Oncology. 2022-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
